AnaBios Human Cardiomyocyte Research Webinar

AnaBios Human Cardiomyocyte Research Webinar 2019-02-11T10:40:44+00:00

AnaBios Webinar:

Reliable Prediction of Drug Effects in the Human Heart Based on Primary Cardiomyocyte Models

Dr. Najah Abi-Gerges, Vice President of Research & Development at AnaBios, will present new human cardiomyocyte research for cardiac safety assessment on Tuesday, March 5, at 10:00am PST. In this informative, 30-minute webinar, you’ll learn about:

  • Novel approaches enabling the study of primary human cardiomyocytes
  • The use of human primary cardiomyocytes for cardiac safety assessment
  • Pro-arrhythmia & contractility risk
  • Human primary atrial cells in atrial fibrillation drug discovery
  • Advancing the understanding of heart failure and new therapies with human primary ventricular myocytes and tissues

After the presentation, we’ll have a brief Q&A session with Dr. Abi-Gerges. Reserve your seat today by completing the sign-up form to the right and clicking the “Submit” button.

DATE: Tuesday, March 5, 2019

TIME: 10:00am-10:30am Pacific Standard Time (PST)

SIGN UP TODAY!

Reserve for your seat for AnaBios’ upcoming webinar, “Reliable Prediction of Drug Effects in the Human Heart Based on Primary Cardiomyocyte Models,” presented by Vice President of Research & Development Dr. Najah Abi-Gerges. Please complete the form below and click the “Submit” button. You will receive an email with important information about the information at the email address provided below.